Skip to main navigation Skip to search Skip to main content

Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials

  • Amanda Jane Leach*
  • , Nicole Wilson
  • , Beth Arrowsmith
  • , Jemima Beissbarth
  • , Edward Kim Mulholland
  • , Mathuram Santosham
  • , Paul John Torzillo
  • , Peter McIntyre
  • , Heidi Smith-Vaughan
  • , Mark D. Chatfield
  • , Deborah Lehmann
  • , Michael Binks
  • , Anne B. Chang
  • , Jonathan Carapetis
  • , Vicki Krause
  • , Ross Andrews
  • , Tom Snelling
  • , Sue A. Skull
  • , Paul V. Licciardi
  • , Victor M. Oguoma
    • Peter Stanley Morris
*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    10 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Immunology and Microbiology

    Pharmacology, Toxicology and Pharmaceutical Science